Skip to main content
CNSY
NASDAQ Life Sciences

CNSide Q3 Gross Billings Hit $1.55M; CMS Pricing Decision Favorable

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$2
Mkt Cap
$14.117M
52W Low
$1.86
52W High
$23.425
52W Position info
7.5% above low
Off High info
91% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

CNSY is trading near its 52-week low of $1.86 (7.5% above the low) on elevated volume (2.4× avg).

Summary

Cerenome's CNSide Diagnostics reported $1.55 million in unaudited Q3 gross billings from 222 tests, with initial cash collections expected in Q4. The company now has 158 million contracted covered lives and received a favorable preliminary CMS pricing decision for its TCE Test, targeting a January 1, 2027 effective date. Management projects an annualized gross billing run rate of $10-12 million by Q4 2026 and plans to launch the CSF Molecular Profile Test and breast cancer assays this quarter. This follows the $20 million financing facility announced September 10 and the Blue Cross Blue Shield of Michigan in-network agreement on September 22. The update provides the first concrete billing figures and Medicare pricing progress, which are key milestones for a company with only $8.6 million in cash and a going concern warning.

At the time of this announcement, CNSY was trading at $2.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.1M. The 52-week trading range was $1.86 to $23.43. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CNSY - Latest Insights

CNSY
Nov 16, 2026, 7:45 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9629
Real-time Price: $0.630 info
Change: -$0.3329 (-35%) info
Market Cap: $6.16M info
CNSY
Nov 13, 2026, 5:19 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9601
Real-time Price: $0.630 info
Change: -$0.3301 (-34%) info
Market Cap: $6.16M info
CNSY
Nov 13, 2026, 5:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.630 info
Change: -$0.340 (-35%) info
Market Cap: $6.16M info
CNSY
Nov 13, 2026, 4:51 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9372
Real-time Price: $0.630 info
Change: -$0.3072 (-33%) info
Market Cap: $6.16M info
CNSY
Nov 04, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.630 info
Change: -$0.680 (-52%) info
Market Cap: $6.16M info